Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ANKRD40 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | KDM8 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | TDRKH | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | BEX2 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | PHLDA3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | POLR3K | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | PLCL2 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
mRNA | GAPT | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | UCHL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | POU2F2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |